Table 1 Clinicopathologic characteristics of patient samples and expression of CENP-H in esophageal carcinoma.
From: Prognostic relevance of Centromere protein H expression in esophageal carcinoma
Characteristics | n(%) |
|---|---|
| Â | (n = 171) |
Gender | Â |
   Male | 129(75.4) |
   Female | 42(24.6) |
Age(y) | Â |
   ≥ 60 | 103(60.2) |
   <60 | 68(39.8) |
Stage | Â |
   I | 10(5.8) |
   II a | 75(43.9) |
   II b | 14(8.2) |
   III | 63(36.8) |
   IV | 9(5.3) |
Histological classification | Â |
   Squamous cell carcinoma | 171(100.0) |
Histological differentiation | Â |
   Well | 55(32.2) |
   Moderate | 72(42.1) |
   Poor | 44(25.7) |
Tumor diameter | Â |
   ≥ 40 mm | 72(42.1) |
   <40 mm | 99(57.9) |
Depth of invasion | Â |
   Submucosa | 12(7.0) |
   Muscularis propria | 58(33.9) |
   Adventitia | 101(59.1) |
pT classification | Â |
   T1 | 13(7.6) |
   T2 | 46(26.9) |
   T3 | 106(62.0) |
   T4 | 6(3.5) |
pN classification | Â |
   YES | 77(45.0) |
   NO | 94(55.0) |
pMetastasis | Â |
   YES | 9(5.3) |
   NO | 162(94.7) |
Vital status(at follow-up) | Â |
   Alive | 59(34.5) |
   Death because of esophageal carcinoma | 109(63.7) |
   Death because of unknown cancer or other than esophageal carcinoma | 3(1.8) |
Expression of CENP-H | Â |
   Negative | 44(25.7) |
   Positive | 127(74.3) |
   Low expression | 54(31.6) |
   High expression | 73(42.7) |